Q86 · Healthcare · CN
Oncology drug launches in China
China: 84 (oncology novel active substance (NAS) launches (cumulative), 2020–2024), +127.0% on 2015–2019.
- 84 Latest · 2020–2024
- +127.0% vs 2015–2019
- 4Records · 3 measures
Irregular · 1 publisher
Oncology novel active substance (NAS) launches (cumulative) in China
Oncology novel active substance (NAS) launches (cumulative)
China, 2015–2019 to 2020–2024
Every record
4 records across 3 measures, newest first within each. Each period opens its record and evidence.
Frequently asked questions
What is the latest oncology drug launches figure for China?
China: 84 oncology novel active substance (NAS) launches (cumulative) in 2020–2024, +127.0% on 2015–2019.
Where does the China data come from?
4 records from 2 documents by IQVIA. Each figure links to its record and its original source evidence.
Cite this page
Free to reuse under CC BY 4.0 with attribution to StatOrigin and the original publisher.
StatOrigin. (2026). Oncology drug launches in China [Data set]. Retrieved October 28, 2026, from https://statorigin.org/statistics/oncology-drug-launches/china
"Oncology drug launches in China." StatOrigin, 2026, https://statorigin.org/statistics/oncology-drug-launches/china. Accessed 28 Oct. 2026.
StatOrigin. "Oncology drug launches in China." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/statistics/oncology-drug-launches/china.
@misc{statorigin_oncology_drug_launches_china_2026, title = {Oncology drug launches in China}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/statistics/oncology-drug-launches/china}, note = {Data set. Accessed 2026-10-28} }